Connect Biopharma Holdings (CNTB) Other Working Capital Changes (2024 - 2026)
Connect Biopharma Holdings' (CNTB) quarterly Other Working Capital Changes came in at -$2.1 million in Q2 2026, down 194.63% year-over-year from $2.2 million in Q2 2025, and down 723.35% quarter-over-quarter from -$257000.0 in Q1 2026.
Analysis
Connect Biopharma Holdings (CNTB) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings has disclosed Other Working Capital Changes across 3 years of filings, most recently posting -$2.1 million for Q2 2026.
- In Q2 2026, Other Working Capital Changes fell 194.63% year-over-year to -$2.1 million; the TTM figure through Jun 2026 stood at -$1.8 million (down 159.79% YoY), while the FY2025 annual figure was $4.1 million, up 330.12% from the prior year.
- Other Working Capital Changes came in at -$2.1 million for Q2 2026 at Connect Biopharma Holdings, down from -$257000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $2.2 million in Q2 2025 to a low of -$2.1 million in Q2 2026.
- Average Other Working Capital Changes over 3 years is -$4900.0, with a median of -$149500.0 recorded in 2024.
- Year-over-year, Other Working Capital Changes soared 5423.81% in 2025 and tumbled 194.63% in 2026.
- Over 3 years, Other Working Capital Changes stood at -$2.0 million in 2024, then jumped by 39.42% to -$1.2 million in 2025, then sank by 72.73% to -$2.1 million in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$2.1 million in Q2 2026, -$257000.0 in Q1 2026, and -$1.2 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Connect Biopharma Holdings | 129.86 Mn | 129.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.12 Mn |
| Jun 30, 2026 | -2.12 Mn |
| Mar 31, 2026 | -257,000.00 |
| Mar 31, 2026 | -257,000.00 |
| Dec 31, 2025 | -1.23 Mn |
| Dec 31, 2025 | -1.23 Mn |
| Sep 30, 2025 | 1.81 Mn |
| Sep 30, 2025 | 1.81 Mn |
| Jun 30, 2025 | 2.24 Mn |
| Jun 30, 2025 | 2.24 Mn |
| Mar 31, 2025 | 1.29 Mn |
| Mar 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | -2.02 Mn |
| Dec 31, 2024 | -2.02 Mn |
| Sep 30, 2024 | 1.49 Mn |
| Sep 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | -42,000.00 |
| Jun 30, 2024 | -42,000.00 |
| Mar 31, 2024 | -1.21 Mn |
| Mar 31, 2024 | -1.21 Mn |